This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer
Alzheimer's Research & Therapy Open Access 26 April 2017
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Garber, K. Genentech's Alzheimer's antibody trial to study disease prevention. Nat Biotechnol 30, 731–732 (2012). https://doi.org/10.1038/nbt0812-731
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0812-731
This article is cited by
-
The Tetramethylpyrazine Analogue T-006 Alleviates Cognitive Deficits by Inhibition of Tau Expression and Phosphorylation in Transgenic Mice Modeling Alzheimer’s Disease
Journal of Molecular Neuroscience (2021)
-
Leveraging preclinical models for the development of Alzheimer disease therapeutics
Nature Reviews Drug Discovery (2020)
-
Everything but amyloid: new thinking prompts FDA revamp
Nature Biotechnology (2018)
-
Evaluation of a DNA Aβ42 vaccine in adult rhesus monkeys (Macaca mulatta): antibody kinetics and immune profile after intradermal immunization with full-length DNA Aβ42 trimer
Alzheimer's Research & Therapy (2017)
-
Hope for anti-amyloid antibodies surges, yet again
Nature Biotechnology (2016)